Experts say private equity can mean big benefits to large urology groups and solo urologists alike. But the real impact of these partnerships on urologists, their patients, and health care in general remains unknown.
These tips, fixes, and workarounds can ease urologists’ EHR-related frustrations.
Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.
Latin-American men are less likely than non-Latin-American Caucasian men to receive guideline-recommended definitive treatment for high-risk localized prostate cancer, according to a recent study.
Activating interferon stimulated gene factor 3 could be a new direction for treating clear cell renal cell carcinoma, according to a recent study.
Widowed bladder cancer patients are more likely to die from the disease than married patients, according to a recent study.
Patients at greatest risk of complications from opioids are older than 65 years, male, obese, have used opioids prior to surgery, or have elevated comorbidity index scores, according to Francis J. McGovern, MD.
Strong evidence has emerged in recent years suggesting opioid prescribers, including well-meaning urologists, have helped to fuel a national crisis and opioid addiction epidemic.
“There are a lot of patients in the greater St. Louis area that seek out my practice because I am a female practicing urology, and they want to see a female,” says Elizabeth Williams, MD.
Imaging with 18F fluciclovine PET/CT (Axumin) tomography identified sites of disease recurrence in a majority of prostate cancer patients with biochemical recurrence and led to changes in treatment course in 59% of men scanned.